Raul H. De Lucas-De Lucas Laguna
La Paz, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Revisiting methylprednisolone aceponate: efficacy, safety and current positioning.
Journal: Drugs in context
Published: May 14, 2026
Shotgun Metagenomic Characterization of Acne Microbiota Before and After Treatment with a Topical Biotechnological Phytocomplex: Understanding Skin Dysbiosis.
Journal: Microorganisms
Published: March 25, 2026
Upadacitinib in children under 12 years with dupilumab-refractory severe atopic dermatitis: a real-world case series.
Journal: Clinical and experimental dermatology
Published: March 01, 2026
Mid-childhood acne conglobata successfully treated with adalimumab.
Journal: JAAD case reports
Published: January 19, 2026
MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics.
Journal: Frontiers in immunology
Published: January 16, 2026
Long-Term Efficacy and Safety of Oleogel-S10 (Birch Triterpenes) for Pediatric Patients With Epidermolysis Bullosa.
Journal: Pediatric dermatology
Published: December 19, 2025
Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring.
Journal: Nutrients
Published: November 28, 2025
Smells like beam spirit - a radiotherapy multiverse of (super) humans in white coats: seven radiotherapy phenotypes that suggest we may be closer to superheroes than we think.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: November 25, 2025
Chromosomal Rearrangements Identified in Three Additional Patients With Generalized Congenital Hypertrichosis With Gingival Hyperplasia Involving the 17q24.2-q24.3 Locus.
Journal: Clinical genetics
Published: October 23, 2025
Oral JAK Inhibitors in Pediatric Generalized Vitiligo Resistant to Conventional Treatment: A Case Series.
Journal: Pediatric dermatology
Published: October 22, 2025
Long-term safety and efficacy of secukinumab in paediatric severe plaque psoriasis: 236-week, Phase 3 trial results.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 14, 2025
[Translated article] Update of the Spanish Consensus Document on Infantile Hemangioma.
Journal: Actas dermo-sifiliograficas
Published: November 22, 2024
Last Updated: 09/26/2026